Neuroblastoma-A Model Disease for Childhood Cancer

Journal of the Formosan Medical Association

Volumn 109, Issue 8, 2010, Pages 555-557

  Chang, Hsiu Hao ^a   Hsu, Wen Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CALRETICULIN; GLUCOSE REGULATED PROTEIN; GLUCOSE REGULATED PROTEIN 75; GLUCOSE REGULATED PROTEIN 78; PROTEIN TYROSINE KINASE A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CELL DIFFERENTIATION; CHROMOSOME 11Q; CHROMOSOME 17Q; GENE AMPLIFICATION; HUMAN; MUTATOR GENE; MYCN GENE; NEUROBLAST; NEUROBLASTOMA; NEUROBLASTOMA CELL; CHILD; FEMALE; GENETICS; MALE; NEOPLASM; NOTE; ONCOGENE MYC; PATHOLOGY; PROGNOSIS;

CHILD; FEMALE; GENES, MYC; HUMANS; MALE; NEOPLASMS; NEUROBLASTOMA; PROGNOSIS;

EID: 77956628722     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(10)60091-5     Document Type: Article

References (11)

1. Brodeur GM Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003, 3:203-216.
2. Mosse YP, Laudenslager M, Longo L, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 2008, 455:930-935.
3. Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet 2007, 369:2106-2120.
4. Shimada H, Ambros IM, Dehner LP, et al. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999, 86:349-363.
5. Cohn SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009, 27:289-297.
6. Ambros PF, Ambros IM, Brodeur GM, et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 2009, 100:1471-1482.
7. Hsu WM, Jen YM, Lee H, et al. The influence of biologic factors on the surgical decision in advanced neuroblastoma. Ann Surg Oncol 2006, 13:238-244.
8. Hsu WM, Lee H, Juan HF, et al. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis. Clin Cancer Res 2008, 14:6237-6245.
9. Chen Y, Takita J, Choi YL, et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 2008, 455:971-974.
10. Liao YF, Wang BJ, Cheng HT, et al. Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem 2004, 279:49523-49532.
11. Chang HH, Lee H, Hu MK, et al. Notch I expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Clin Cancer Res 2010, [In press].